SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amerise Biosciences - Quaterly Results

04 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 0.00 millions against Rs. 65.66 millions recorded during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -0.20 millions as compared to Net Profit of Rs. 2.85 millions of corresponding quarter ended March 2022Operating profit Margin for the quarter ended March 2023 slipped to -0.20% as compared to 2.85% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 0.00 65.66 0.00 0.09 95.77 -99.91 0.09 95.77 -99.91
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.20 2.85 -107.02 -1.19 5.48 -121.72 -1.19 5.48 -121.72
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.20 2.85 -107.02 -1.19 5.48 -121.72 -1.19 5.48 -121.72
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.20 2.85 -107.02 -1.19 5.48 -121.72 -1.19 5.48 -121.72
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.20 2.85 -107.02 -1.19 5.48 -121.72 -1.19 5.48 -121.72
Equity 66.07 66.07 0.00 66.07 66.07 0.00 66.07 66.07 0.00
PBIDTM(%) 0.00 4.34 0.00 -1322.22 5.72 -23207.69 -1322.22 5.72 -23207.69

Amerise Biosciences Share Price

0.72 0.03 (4.35%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×